Last reviewed · How we verify
SK-1405
At a glance
| Generic name | SK-1405 |
|---|---|
| Sponsor | Sanwa Kagaku Kenkyusho Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus (PHASE2)
- A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 (PHASE1)
- A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |